About: Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 05 July 2011

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 2012 (uk) article scientifique publié en 2011 (fr) im Juli 2011 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 2011 (ast) scientific article published on 05 July 2011 (en)
publication date	wds:Q57218945-387EACB7-6C47-4F4C-912A-BF2E23463DFD
publication date	2011-07-05 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57218945-3FA9E80E-EFE0-43D9-A10B-217E6FFCC532
language of work or name	English
cites work	wds:Q57218945-01F538ED-19CE-4D59-B9F9-658774CB2969 wds:Q57218945-0C9C5E0B-FA90-4AED-BCFF-6D4D056F33CA wds:Q57218945-166FCB4B-827E-4773-8B5C-DDC2CD091CA2 wds:Q57218945-2A184672-74F3-463F-95C6-1C127E3FC001 wds:Q57218945-2FA33FF7-D746-46D6-B296-C82F0B96D573 wds:Q57218945-318E40D7-E30F-4D39-8BCD-9DC7E3DF78BA wds:Q57218945-335060E9-A5AF-45A4-B62E-2DC49EB82C8E wds:Q57218945-383BDB41-AF9D-4F48-B376-BB2EC209D950 wds:Q57218945-3DC39ABE-7D65-46FE-9778-028B07578F4C wds:Q57218945-3F522940-9B82-4C99-AB42-FD91EDFFBFFA wds:Q57218945-5898830A-1315-413A-AA9F-EFC856B62C88 wds:Q57218945-6E21CC46-3C84-4400-9880-5D6BAC6A12C6 wds:Q57218945-787FB90C-E187-4E14-87CC-C91A54BCE499 wds:Q57218945-8157D7A8-B0B8-4B6A-A768-65632285E977 wds:Q57218945-825EA45E-9CE3-462C-903B-E9CF31A217C1 wds:Q57218945-88E9FF1A-EF48-4110-B3FD-643D68C96BE9 wds:Q57218945-8900A902-6272-4CE7-94D0-EAF3B8E80B30 wds:Q57218945-939B6591-0648-4EB8-A9AB-FAF0BC30E941 wds:Q57218945-9D381A60-8A3C-4590-95D3-CA401B014BAA wds:Q57218945-A3C35CBA-EBFE-4586-A4E6-6F784B345315 wds:Q57218945-AAE0F9BD-C829-4212-B388-E52124AEF664 wds:Q57218945-AC8C862E-C45B-46D1-BD9B-855A851706E0 wds:Q57218945-AE67AA5C-F79A-462C-9BCA-59D36C80A636 wds:Q57218945-B21EE704-950C-46D5-89A7-B1B050E72B2E wds:Q57218945-B4FA5E6F-6A49-44E6-B5F5-FA331F267E50 wds:Q57218945-B6AC95B3-FE53-4EC8-A48F-A6216AB71C49 wds:Q57218945-B791DFE3-A771-4469-AD4D-FF5EFBDDF361 wds:Q57218945-BCD732D1-4873-4E8E-97D1-D8A7E2F32161 wds:Q57218945-C591D9B6-6385-4FF2-9E9B-CD40A7BFA046 wds:Q57218945-C76CB691-8A7D-490A-A894-4FBEC59BADF1 wds:Q57218945-C85F6453-C3EB-458D-8FE8-AE79955AB6E5 wds:Q57218945-D0312406-484B-46C1-A137-DC10DB7F8C53 wds:Q57218945-D501B541-EA9B-4725-8AEA-A95A4037360A wds:Q57218945-D6D93537-FA9D-4815-B10B-159478E07763 wds:Q57218945-E7486BD6-4F92-4AE0-96BC-0073B595E8AA wds:Q57218945-F63D0550-A8BB-4354-9BC9-8DEE66C95D0D
cites work	Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism Phosphate and the parathyroid PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients. Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. FGF23-parathyroid interaction: implications in chronic kidney disease The parathyroid is a target organ for FGF23 in rats Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences Interpretation of serum calcium in patients with abnormal serum proteins. The calcium-sensing receptor in bone cells: a potential therapeutic target in osteoporosis Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy? Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency. Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism Is the volume of the parathyroid gland a predictor of Maxacalcitol response in advanced secondary hyperparathyroidism? Endocrine functions of bone in mineral metabolism regulation. Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis Mineral metabolism management in hemodialysis patients with secondary hyperparathyroidism in Japan: baseline data from the MBD-5D. Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients.
author name string	wds:Q57218945-B2C4E09D-2D52-47D1-B4BA-A813404352BE
author name string	Masahiro Koizumi
rdfs:label	Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism (en) Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism (nl)
skos:prefLabel	Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism (en) Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism (nl)
name	Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism (en) Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism (nl)
author	wds:Q57218945-15A0768E-0C3E-4068-AFFD-25EA3AC02094 wds:Q57218945-5F086F14-43DD-4317-881A-961961793ADB wds:Q57218945-8B1EEFDB-36FA-4D47-9D89-B3004C0E4544 wds:Q57218945-F713F91A-4129-484C-9DCD-83D09D247C2F
author	Masafumi Fukagawa Hirotaka Komaba Akira Fujimori Shohei Nakanishi
title	wds:Q57218945-5293D22E-FB1F-43CD-B315-AF024A28D024

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software